Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Percocet"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringOxycodone / Acetaminophen
brandStringPercocet, Endocet, Roxicet, Tylox, Primlev
structureFile
classesList of String, delimiter: ,[[:Category:Opioid_analgesics|Opioid analgesic]] [[:Category:Non-opioid_analgesics|Non-opioid analgesic (acetaminophen)]] [[:Category:Schedule_II_controlled_substances|Schedule II controlled substance]] [[:Category:Fixed-dose_combinations|Fixed-dose combination]]
mechanismString'"`UNIQ--vote-000014DD-QINU`"' The combination is the most-prescribed opioid analgesic in the US for moderate-to-severe acute pain. CPIC PGx guidance addresses CYP2D6-driven exposure variation'"`UNIQ--ref-000014DE-QINU`"'.
usesString'"`UNIQ--vote-000014DF-QINU`"', '"`UNIQ--vote-000014E0-QINU`"', '"`UNIQ--vote-000014E1-QINU`"'
starting_doseString5 mg / 325 mg PO every 4-6 hours as needed; total acetaminophen <3 g/d
preparationsStringOxycodone/acetaminophen 2.5/325, 5/325, 7.5/325, 10/325 mg tablets; 5/325 mg/5 mL solution
fda_maxStringAcetaminophen 4 g/d absolute (3 g/d conservative); oxycodone titrated to effect
pill_idText
routesList of String, delimiter: ,Oral
onsetString10-30 minutes
durationString4-6 hours
halflifeStringOxycodone 3-5 hours; acetaminophen 1-3 hours'"`UNIQ--ref-000014E2-QINU`"'
bioavailabilityString~60-87% oxycodone (high and predictable, less CYP-genotype-dependent than codeine or hydrocodone); 85-98% acetaminophen'"`UNIQ--ref-000014E3-QINU`"'
pregnancyStringLimited use in pregnancy; chronic third-trimester opioid exposure produces neonatal opioid withdrawal syndrome and respiratory depression at delivery.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Schedule II|Schedule II controlled substance]] in US. Acetaminophen content limited to ≤325 mg per dosage unit (FDA 2014)